Branded AUBAGIO® (teriflunomide) has 18+ years of ongoing clinical studies and real-world patient experience. This may give you peace of mind as you and your doctor consider whether AUBAGIO could help put your relapsing MS in the background.
Every relapsing MS treatment is different, but each one comes with certain side effects. It is important to review the possible side effects of any medication you take.
AUBAGIO is processed by the liver. Your healthcare provider will test your liver enzymes before going on AUBAGIO and for the first 6 months on AUBAGIO to make sure you are tolerating treatment. Most people who had elevated liver enzymes during clinical trials returned to normal over time.
If you experience any of the following side effects while taking AUBAGIO, speak with your healthcare provider right away.
In addition to the risk of liver problems, including liver failure that can be life-threatening and may require a liver transplant, and the risk of harm to an unborn baby, other possible serious side effects include:
Side Effects | AUBAGIO | Placebo | |
---|---|---|---|
14 mg (1002 people) |
7 mg (1045 people) |
(997 people) | |
Headache | 16% | 18% | 15% |
Abnormal liver test results | 15% | 13% | 9% |
Diarrhea | 14% | 13% | 8% |
Hair thinning or loss | 13% | 10% | 5% |
Nausea | 11% | 8% | 7% |
Of course, everyone reacts differently to treatment. And not everyone experiences side effects with AUBAGIO. Talk to your healthcare provider if you’re concerned about potential side effects. You can also speak with one of our MS One to One Nurses at 1-855-676-6326.
Side Effects | AUBAGIO | Placebo | |
---|---|---|---|
14 mg (1002 people) |
7 mg (1045 people) |
(997 people) | |
Diarrhea |
0.4% = 4 people |
0.5% = 5 people |
0.1% = 1 person |
Nausea |
0.3% = 3 people |
0.1% = 1 person |
0% = 0 people |
Hair thinning or loss |
1.3% = 13 people |
0.2% = 2 people |
0.1% = 1 person |
Abnormal liver test results |
2.6% = 26 people |
3.3% = 34 people |
2.3% = 23 people |
Headache |
0% = 0 people |
0% = 0 people |
0.3% = 3 people |
AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Are of childbearing potential and not using effective birth control.
It is not known if AUBAGIO passes into breast milk. Your healthcare provider can help you decide if you should take AUBAGIO or breastfeed — you should not do both at the same time.
If you are a man whose partner plans to become pregnant, you should stop taking AUBAGIO and talk with your healthcare provider about reducing the levels of AUBAGIO in your blood. If your partner does not plan to become pregnant, use effective birth control while taking AUBAGIO.
AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly.
Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), over-the-counter medicines, vitamins or herbal supplements.
The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you.
Consult your healthcare provider if you have questions about your health or any medications you may be taking, including AUBAGIO.
Please click here for full Prescribing Information, including boxed WARNING and Medication Guide.
IMPORTANT SAFETY INFORMATION
Do not take AUBAGIO if you have severe liver problems. AUBAGIO may cause serious liver problems, including liver failure that can be life-threatening and may require a liver transplant. Your risk may be higher if you already have liver problems or take other medicines that affect your liver. Your healthcare provider should do blood tests to check your liver within 6 months before you start AUBAGIO and monthly for 6 months after starting AUBAGIO. View More